Document:

<Page>

                                                                    EXHIBIT 10.2

                                       *** CERTAIN CONFIDENTIAL INFORMATION
                                       CONTAINED IN THIS DOCUMENT (INDICATED
                                       BY ASTERISKS) HAS BEEN OMITTED AND
                                       FILED SEPARATELY WITH THE SECURITIES
                                       AND EXCHANGE COMMISSION PURSUANT TO A
                                       REQUEST FOR CONFIDENTIAL TREATMENT
                                       UNDER 17 C.F.R. SECTIONS 200.80(B)(4),
                                       200.83 AND 230.406.

                           SOFTWARE LICENSE AGREEMENT

         This Software License Agreement ("Agreement") is entered into under
seal this 16th day of June, 1999 (the "Effective Date") by and between Segami
Corporation, a Maryland corporation having its principal offices at 12624 Golden
Oak Drive, Ellicott City MD 21042 ("Segami"), and Digirad Corporation
("Digirad"), a Delaware corporation having its principal offices at 9350 Trade
Place. San Diego CA 92126.

                             Statement of Intention

         A.       Segami is in the business of the development and sale of
                  software for gamma camera image acquisition, processing and
                  display. Segami's current software is called ***

         B.       Digirad desires to purchase software from Segami for the
                  purpose of gamma camera image acquisition, processing and
                  display which will interface with Digirad's solid state gamma
                  camera.

         C.       Digirad desires to package the *** software and Digirad's
                  hardware for resale as a single product, identifiable only as
                  a Digirad product.

         In consideration of the mutual promises and covenants herein contained,
the receipt and sufficiency of which are hereby acknowledged, the parties agree
under seal as follows:

         1.       DEFINITIONS. For the purposes of this Agreement, the following
terms, when used herein, have the following meaning.

"Base Software"-The existing *** software described in EXHIBIT D hereto in
object and executable code forms, and all updates, enhancements, revisions,
modifications, modules and or sub-modules thereto and all permitted copies,
except that Base Software does not include the Interface Development.
"Interface Development"-The new code written and modifications made to the Base
Software which will allow use of the Base Software with Digirad's current
hardware, in object and executable code forms, and all updates, enhancements,
revisions, modifications, modules and or sub-modules thereto and all permitted
copies.

"Product" - Digirad's solid state gamma camera bundled together with the Base
Software and Interface Development.

         2.       LICENSE TO DIGIRAD. Subject to all the terms of this
Agreement, Segami grants to Digirad a nonexclusive worldwide, fully paid-up
license:

         (a)      to sublicense the Base Software to end-users only in
connection with the sale and use of the Products; any such sublicense shall be
pursuant to a sublicense agreement for Segami's

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                  Page 1 of 10
<Page>

benefit that contains applicable similar restrictions and obligations imposed on
Digirad hereunder.

         (b)      to use, adopt, reproduce, display, perform, test, demonstrate
and distribute the Base Software as necessary to market, sale and distribute the
Products.

         (c)      sublicense to third parties the distribution rights for the
Products and Base Software; any such sublicense shall be pursuant to a
sublicense agreement for Segami 's benefit that contains applicable similar
restrictions and obligations imposed on Digirad hereunder.

The balance of this Section 2 notwithstanding, the license granted to Digirad
shall not include the right to sublicense, sell or distribute the Base Software
independently and separate from the Product, with the understanding that Digirad
may demonstrate the Base Software or distribute demonstration models of the Base
Software, limited in function, for use on systems independent from the Product.

         3.       USE/LICENSE FEES.

                  3.1      USE. Segami hereby grants Digirad the right to
package and bundle the Base Software with the Product, the Interface Development
and Digirad hardware for sale to end-users by Digirad or its subdistributors.

                  3.2      LICENSE FEES. Digirad shall pay a License Fee (the
"License Fee") to Segami, in accordance with the attached Exhibit A, for each
copy of the Base Software distributed to any end-user, unless otherwise agreed
upon in writing by Segami. Payment of the License Fee shall be made by Digirad
and tendered to Segami at the sooner of *** days after customer payment or ***
days after customer installation. Digirad will receive a reasonable number of
demonstration versions of the Base Software including the dongle keys ("Keys")
for using such versions ("Demo Versions") to be used for customer demonstrations
and/or Digirad roadshows (not for sale to customers). Segami shall deliver the
Demo Versions within *** days upon written request from Digirad.

                  3.3      AUDIT. Segami shall have the right to audit the
books, financial accounts and documents of Digirad *** in each calendar year for
which this contract is in force, to verify the number of copies of the Base
Software disseminated by Digirad. Segami shall employ an independent Certified
Public Accountant at its own cost and expense for such audit. Segami shall give
Digirad a minimum of *** days prior written notification of the audit. Digirad
shall not unreasonably withhold its cooperation in the audit.

         4.       INTERFACE DEVELOPMENT.

                  4.1      DEVELOPMENT. Segami agrees to undertake and complete
the code design, programming and testing of the Interface Development. Interface
Development shall be in accordance with the specifications on the attached
Exhibit B (the "Specifications") and the delivery schedule attached hereto as
Exhibit C (the "Delivery Schedule"). Segami shall be

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                  Page 2 of 10
<Page>

responsible for obtaining and maintaining operational status and approvals of
the Base Software and Interface Development (and any new versions or
improvements thereto) under FDA, CE and other regulatory authorities or
agencies. Segami agrees that its conduct in performing its obligations under
this Agreement shall conform in all material respects to all applicable laws and
regulations of the U.S. and foreign governments (and political subdivisions
thereof).

                  4.2      ACCEPTANCE. Digirad will, by written notice, accept
or reject any portion of the Interface Development delivered (individually, the
"Deliverable(s)") within *** days after receipt. Failure to give notice of
acceptance or rejection within that period will constitute acceptance. Digirad
may reject any Deliverable only if the Deliverable fails to meet the
Specifications or, at the fault or failing of that Deliverable alone, the
Product cannot operate in a commercially reasonable manner. If Digirad properly
rejects the Deliverable, Segami will correct the failures properly specified in
the rejection notice within *** days of the rejection notice. When it believes
that it has made the necessary corrections, Segami will again deliver the
Deliverable to Digirad and the acceptance/rejection/correction provisions above
shall be reapplied until the Deliverable is accepted; provided, however, that
upon the *** or any subsequent rejection or if the corrections are not made
within *** days of the initial rejection, Digirad may at its option terminate
this Agreement by immediate written notice unless the Deliverable is accepted
during the notice period.

         5.       COMPENSATION FOR INTERFACE DEVELOPMENT. Digirad shall make
payments to Segami in accordance with the Delivery Schedule. Each payment will
be in U.S. dollars from the United States and will be made no later than ***
days from the occurrence of the event specified in the Delivery Schedule for
which payment is due.

         6.       OWNERSHIP RIGHTS. As between the parties Segami shall retain
all right title and interest, including all patent, copyright, trade secret,
trademark, mask work or other rights, in the Base Software, or any other idea or
product conceived or reduced to form by Segami, its agents or assigns as of the
Effective Date. Digirad shall have all right, title and interest, in the
Interface Development. The parties hereby make any assignments necessary to
accomplish the foregoing ownership provisions.

         7.       SUPPORT/MAINTENANCE.

                  7.1      SUPPORT.  During the term of this Agreement:

                           (1)      Segami shall use its best efforts to respond
within *** days after receipt of written notice of verifiable defects, and
propose a plan for prompt and effective remedy, and shall provide general
guidance concerning the Base Software or Interface Development. Defects shall be
reported in writing via electronic mail or facsimile to Segami at the
telephone/email numbers provided by Segami to Digirad from time to time.

                           (2)      Segami shall inform Digirad promptly of any
changes in the Base Software or delivery schedules.

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                  Page 3 of 10
<Page>

                           (3)      Subject to the other terms and conditions of
this Agreement, Segami shall use its reasonable best efforts to promptly fill
Digirad's orders for Keys. Promptly following the execution of this Agreement,
Segami shall place *** Keys in escrow. If Segami materially fails to provide a
sufficient number of Keys to Digirad for delivery of Products to end-users,
after *** days written notice to Segami, Digirad shall be entitled to receive
from escrow any or all of the Keys. If Segami fails to provide a sufficient
number of Keys to Digirad for delivery of Products to end-users, after *** days
written notice to Segami, Digirad shall be entitled to a fully executed purchase
order from Segami to the Key manufacturer ("Escrow Materials") authorizing the
Key manufacturer to provide directly to Digirad those Keys reasonably necessary,
in Digirad's sole discretion, for Digirad to sell and install Product. In
support of the foregoing and promptly after execution of this Agreement, Segami
will place in escrow (pursuant to the terms of an escrow agreement in form
mutually acceptable to the parties hereto) the Escrow Materials as they exist at
the date of the Agreement. Segami will update the escrow with any new or
modified Escrow Materials and Keys promptly as it becomes necessary and will
notify Digirad when it does so. *** ***

                           (4)      Segami agrees to provide *** standard
training *** for Digirad personnel. *** shall be given at Digirad's main office
on a schedule reasonably acceptable to Segami but commencing no later than ***
days after Digirad's written request. ***
                                      ***
***

                           (5)      Segami shall provide free technical support
to Digirad personnel up to *** during the first year, and *** per year after
that. This does not include time spent on developments set forth in Section 4 or
Section 7.1(1). Segami shall provide Digirad with all the user's documentation
in its possession.

                  7.2      MAINTENANCE RELEASES. In the exercise of its sole
discretion and from time to time, Segami may develop and make available
maintenance release for the Base Software at no cost to Digirad. Such
maintenance release shall be patches for the purpose of correcting any
deficiencies in the Base Software which may become apparent to Digirad and
Segami after successful delivery of the Interface Development.

                  7.3      ENHANCEMENTS/UPGRADES. In the exercise of its sole
discretion and from time to time, Segami may develop and make available for sale
through Digirad to end-users, and at an additional license fee to Segami, to be
negotiated in good faith by the Parties, substantially upgraded versions of the
Base Software which incorporate significant functional changes or additions, or
substantially improved performance.

         8.       CONFIDENTIALITY. Each party agrees that all code, inventions
algorithms, know-how and ideas and all other business, technical and financial
information they obtain from the other are confidential information and property
of the disclosing party ("Confidential Information"). Each party shall use
Confidential Information of the other party which is disclosed to it only for
the purposes of this Agreement and shall not disclose such Confidential

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                  Page 4 of 10
<Page>

Information to-any third party, without the other party's prior written consent,
other than to Segami's subcontractors, subdistributors and employees on a
need-to-know basis. Each party agrees to take measures to protect the
confidentiality of the other party's Confidential Information that, in the
aggregate, are no less protective than those measures it uses to protect the
confidentiality of its own Confidential Information, but at a minimum, each
party shall take reasonable steps to advise their employees, subcontractors and
subdistributors of the confidential nature of the Confidential Information and
of the prohibitions on copying or revealing such Confidential Information
contained herein. The parties each agree to require that the other party's
Confidential Information be kept in a reasonably secure location.
Notwithstanding anything to the contrary contained in this Agreement neither
party shall be obligated to treat as confidential, or otherwise be subject to
the restrictions on use, disclosure or treatment contained in this Agreement for
any information disclosed by the other party (the "Disclosing party") which: (1)
is rightfully known to the recipient prior to its disclosure by the Disclosing
Party; (2) is generally known or easily ascertainable by non-parties of ordinary
skill in computer process design or programming or in the business of the
client; (3) is released by the Disclosing Party to any other person, firm or
entity (including governmental agencies or bureaus) without restrictions; (4) is
independently developed by the recipient without any reliance on Confidential
Information; or (5) is or later becomes publicly available without violation of
this Agreement or may be lawfully obtained by a party from a non-party. Neither
party will be liable to the other for inadvertent or accidental -disclosure of
Confidential Information if the disclosure occurs notwithstanding the party's
exercise of the same level of protection and care that such party customarily
uses in safeguarding its own confidential information.

         Notwithstanding the foregoing, all Confidential Information developed
by Segami, including but not limited to the Interface Development, in connection
with this Agreement shall be deemed Confidential Information of Digirad
disclosed by Digirad to Segami and exceptions (1) and (4) above will not be
applicable thereto.

         9.       EXPORT CONTROL. Each party hereby agrees to comply with all
export laws and restrictions and regulations of the Department of Commerce or
other United States or foreign agency or authority, and not to export, or allow
the export or re-export of any proprietary information or software or any copy
or direct product thereof in violation of any such restrictions, laws or
regulations.

         10.      TERMINATION

                  10.1     TERMINATION BY DIGIRAD. Digirad may terminate this
Agreement if Segami is in material breach of, or default under, this Agreement
and such breach or default is not cured within *** days after Digirad delivers
written notice of such breach or default to Segami.

                  10.2     TERMINATION BY SEGAMI. Segami may terminate this
Agreement if Digirad is in material breach of or default under, this Agreement
and such breach or default is not cured within *** days after written notice to
Digirad. A material breach of and default

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                  Page 5 of 10
<Page>

under, this Agreement by Digirad shall include, without limitation, the
occurrence of the failure of Digirad to pay any License Fee when due.

                  10.3     SURVIVAL. Sections 5-15 of this Agreement, any
accrued rights to payment, any licenses granted in this Agreement that are
expressly perpetual and any remedies for breach of this Agreement shall survive
termination.

         11.      LIMITATION OF LIABILITY.

                  (a)      Except under Section 8 and the indemnity provisions
of Section 12, neither party nor its affiliates shall, under any circumstances,
be liable to the other party or its affiliates for any claim based upon any
third party claim or for consequential, incidental, indirect, punitive,
exemplary or special damages of any nature whatsoever, or for any damages
arising out of or in connection with any malfunctions, delays, loss of data,
loss of profit, interruption of service or loss of business or anticipatory
profits, even if a party or its affiliates have been apprised of the likelihood
of such damages occurring.

                  (b)      ***
                           ***
                           ***

         12.      INDEMNIFICATION

                  (a)      The parties each agree to indemnify, defend and hold
harmless the other from and against any and all amounts, including legal fees
and other out-of-pocket expenses, payable under any judgment, verdict, court
order or settlement for death or bodily injury or the damage to or loss or
destruction of any real or tangible personal property to the extent arising out
of the indemnitor's negligence, gross negligence, or willful misconduct in the
performance of this Agreement.

                  (b)      Segami agrees to indemnify, defend and hold harmless
Digirad, its distributors and end-users from and against any and all amounts,
including legal fees and other out-of-pocket expenses, payable under any
judgment, verdict, court order or settlement to the extent resulting from any
third party allegation that the Base Software or the work performed by Segami
under this Agreement infringes such third party's intellectual property rights,
including, without limitation, patent, copyright or trade secret. Should
Digirad's use of work performed by Segami be determined to have infringed, or if
in Segami's and Digirad's reasonable judgment such use is likely to be
infringing, *** *** ***

                  (c)      Digirad agrees to indemnify, defend and hold harmless
Segami from and against any and all amounts payable under any judgment, verdict,
court order or settlement to the extent resulting from any affiliated third
party allegation that the work performed by Segami under this Agreement
infringes such third party's intellectual property rights to the extent
attributable to software, hardware, data, knowledge or services provided by
Digirad.

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                  Page 6 of 10
<Page>

                  (d)      The indemnities in this paragraph are contingent
upon: (1) the indemnified party promptly notifying the indemnifying party in
writing of any claim which may give rise to a claim for indemnification
hereunder; (2) the indemnifying party being allowed to control the defense and
settlement of such claim; and (3) the indemnified party cooperating with all
reasonable requests of the indemnifying party (at the indemnifying party'
expense) in defending or settling such claim. The indemnified party shall have
the right, at its option and expense, to participate in the defense of any
action, suitor proceeding relating to such a claim through a counsel of its own
choosing.

         13.      WARRANTIES. Segami warrants that it has and will obtain
agreements with its employees and contractors sufficient to allow it to provide
Digirad with the assignments and licenses to intellectual property rights
contemplated in this Agreement. Segami also warrants that the Base Software and
Interface Development and any part thereof shall meet the Specifications, and
perform in a commercially reasonable manner until the later of (i) *** years
from the final date of delivery on the Delivery Schedule and (ii) with respect
to each product containing the Base Software and/or Interface Development, ***
year from the date of installation of such product by Digirad or its distributor
to an end-user. If Digirad finds that the Products, or part thereof fail to meet
the above warranty, Segami shall, at its option, immediately repair or replace
the Base Software and/or Interface Development or part thereof at its costs and
expenses without prejudice to any other rights and remedies of Digirad under
this Agreement or applicable law. If a Deliverable is rejected, the warranty
will extend accordingly from any adjusted final delivery date. Except for
Section 14, notwithstanding anything to the contrary contained in this
Agreement, Segami makes no other warranties, express or implied, or whether
arising by operation of law, course of performance or dealing, custom, usage in
the trade or profession or otherwise including without limitation implied
warranties of merchantability and fitness for a particular purpose.

         14.      MILLENNIUM WARRANTY.

                  14.1     GENERAL, Other sections of this Agreement
notwithstanding, Segami represents and warrants that for a period of four (4)
years after the Effective Date, the Base Software and the Interface Development
will be able to accurately: (a) process any date-roll event with no adverse
impact on the functionality of the software including without limitation, the
producing of error(s) or abnormal interruption; (b) process date-data
calculations including, without limitation, computation, comparisons,
sequencing, sorts and extracts and return and display date-data in a consistent
manner regardless of the dates used in such date-data whether before, on,
during, or after January 1, 2000; (c) process any date-data computations that
can be expected from the software if used for its intended purpose, regardless
of the date in time on which the processes are actually performed and regardless
of the date-data input, whether before, on, during or after January 1, 2000; (d)
exchange date-data related information with other hardware, firmware or software
with which it interacts, provided that the interacting hardware, firmware or
software is itself capable of exchanging accurate date-data; (e) accept and
respond to four-digit year-date input in a manner that resolves any ambiguities
as to the century in a defined predetermined and appropriate manner; and (f)
store and display date-data in ways that are unambiguous as to the determination
of the century. No date-data shall cause such software to

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                  Page 7 of 10
<Page>

perform an abnormally ending routine or function within the processes or
generate incorrect values or invalid results. For purposes of the foregoing, a
date-rollover event is defined as any transaction between one calendar year and
the following calendar year including, without limitation, any time, date and
day-of-the-week progressions and any regularly scheduled leap events. Date-data
is defined as any data, formula, algorithm, process, input or output, which
includes, calculates or represents a date, day or time, a reference to a date,
day or time, or a representation of a date, day or time.

                  14.2     SPECIAL REMEDIES. In the event of any breach of the
warranties and covenants contained in this section, provided that such breach is
not cured by Segami within *** days following receipt of written notice of such
breach, in addition to other rights and remedies that may be available to
Digirad under this Agreement, Segami shall be responsible for: (a) any costs of
repairing, replacing and/or correcting the affected software; and (b) cover and
other similar damages that are incurred by Digirad as a result of Segami's
breach of this warranty.

         15.      MISCELLANEOUS

                  15.1     BINDING NATURE. This Agreement shall be binding upon
and shall inure to the benefit of the parties to this Agreement and their
respective successors and permitted assigns. Segami shall not have any right or
ability to assign, transfer, or sublicense any obligations or benefit under this
Agreement without the written consent of Digirad, except that Segami may assign
and transfer this Agreement and its rights and obligations hereunder to any
third party who succeeds to substantially all its business or assets.

                  15.2     ENTIRE AGREEMENT. This Agreement constitutes the
entire agreement between the parties and there are no representations,
warranties, covenants, or obligations except as set forth in this Agreement.
This Agreement supersedes all prior or contemporaneous agreements
understandings, negotiations and discussions, written or oral, of the parties to
this Agreement, relating to any transaction contemplated by this Agreement.

                  15.3     SEVERABILITY. Each provision of this Agreement shall
be considered separable and if for any reason any provision or provisions in
this Agreement are determined to be invalid arid contrary to any existing or
future law, that invalidity shall not impair the operation of this Agreement or
affect those portions of this Agreement which are valid.

                  15.4     ARBITRATION. If any dispute or controversy arises
among the parties to this Agreement concerning any provision of this Agreement,
that dispute or controversy shall be submitted for resolution to a board of
arbitration in *** *** *** Such arbitration shall be conducted pursuant to the
rules of the American Arbitration Association (the "AAA") or other governing
rules and *** *** ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                  Page 8 of 10
<Page>

                  15.5     NO AGENCY. This Agreement shall not be deemed to
constitute the parties hereto as partners, joint venturers, nor shall either
patty hereto be deemed to be an agent of any nature, kind and description
whatsoever of the other.

                  15.6     JURISDICTION AND VENUE. This Agreement shall be
governed, enforced, performed and construed in accordance with the laws of the
State of *** *** Subject to the provisions of Section 15.4 hereof each of the
parties hereto hereby submits to the exclusive jurisdiction of the state and/or
federal courts located within the State of *** for any suit, hearing or other
legal proceeding of every nature, kind and description whatsoever in the event
of any dispute or controversy arising hereunder or relating hereto, or in the
event any ruling, finding or other legal determination is required or desired
hereunder.

                  15.7     ATTORNEYS FEES. In the event that legal proceedings
are commenced in connection with this Agreement or the transactions contemplated
hereby, the party or parties *** *** ***

                  15.8     AMBIGUITY. The parties acknowledge that each party
and its respective counsel have reviewed and revised this Agreement and that the
normal rule of construction to the effect that any ambiguities are to be
resolved against the drafting party shall not be employed in the interpretation
of this Agreement or any amendments or exhibits, or schedules hereto.

                  15.9     EXHIBITS. The exhibits attached hereto and each
certificate, schedule, list summary or other document provided or delivered
pursuant to this Agreement or in connection with the transactions contemplated
hereby are incorporated herein by this reference and made a part hereof.

                  15.10    COUNTERPARTS. Provided that all parties hereto
execute a copy of this Agreement, this Agreement may be executed in
counterparts, each of which shall he deemed an original and all of which
together shall constitute one and the same instrument. Executed copies of this
Agreement may be delivered by facsimile transmission or other comparable
electronic means.

                  15.11    VOLUNTARY AGREEMENT. The parties hereto represent
that they have carefully read the foregoing Agreement, understood its terms,
consulted with an attorney of their choice, and voluntarily signed the same as
their own free act with the intent to be legally bound thereby. The terms of
this Agreement are contractual and not a mere recital.

                  15.12    FORCE MAJEURE. Neither party shall be liable to the
other for its failure to perform any of its obligations under this Agreement
during any period in which such performance is delayed due to circumstances
beyond its control, including acts of God or public authorities, was and war
measures, civil unrest, natural disasters or delays in transportation, delivery
or supply.

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                  Page 9 of 10
<Page>

                  15.13    NOTICE. All notices under this Agreement shall be in
writing and shall be deemed given when personally delivered or three days after
being sent prepaid certified or registered United States mail to the address of
the party to be noticed as set forth below or such other addresses as such party
last provided to the other by notice:

                           Digirad:         Digirad Corporation
                                            9350 Trade Place
                                            San Diego CA 92126
                                            Attn: President and COO

                           Segami:          Segami Corporation
                                            12624 Golden Oak Drive
                                            Ellicott City MD 21042
                                            Attn: Philippe Briandet Ph.D.

                           Copy to:         Christopher S. Young, Esq.
                                            3440 Ellicott Center Drive
                                            Ste. 203
                                            Ellicott City MD 21043

IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed
under seal as of the date first above written.

ATTEST:                                        Digirad Corporation

By:      /s/ ILLEGIBLE                       By:     /s/ Scott Huennekens
   -------------------------------              --------------------------------
Title:        Controller           (SEAL)    Title:    President & COO
      ----------------------------                 -----------------------------

                                             Segami Corporation

By:         /s/ ILLEGIBLE       (Secretary)  By:        /s/ ILLEGIBLE
   -------------------------------                ------------------------------
Title:                             (SEAL)    Title:      President
      ----------------------------                 -----------------------------

                                  Page 10 of 10
<Page>

                                    EXHIBIT A
                                PRICING SCHEDULE

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                      A-1
<Page>

<Page>

                                    EXHIBIT B

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-1
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-2
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-3
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-4
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-5
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-6
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-7
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-8
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-9
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-10
<Page>

                                       ***
                                       ***
                                       ***

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

--------------------------------------------------------------------------------
Information contained in this document is proprietary to DIGIRAD Corporation and
should not be released outside of the company without written permission of the
company.
--------------------------------------------------------------------------------

                                      B-11
<Page>

                                    EXHIBIT C
                                DELIVERY SCHEDULE

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                      C-1
<Page>

                                    EXHIBIT D
                             SEGAMI'S BASE SOFTWARE

*** Portions of this page have been omitted pursuant to a request for
    Confidential Treatment and filed separately with the Commission.

                                      D-1
<Page>

           AMENDMENT TO THE DIGIRAD-SEGAMI SOFTWARE LICENSE AGREEMENT

     This Amendment to the Digirad-Segami Software License Agreement
("Addendum"), is entered into under seal this 15TH day of NOV, 2001, by and
between ") by and between Segami Corporation, a Maryland corporation having its
principal offices at Segami Corporation 8335 Guilford Rd., Suite I, Columbia MD
21046 ("Segami"), and Digirad Corporation ("Digirad"), a Delaware corporation
having its principal offices at 9350 Trade Place, San Diego, CA 92126.

                                   Background

     A.   Digirad and Segami entered into a written contract on JUNE 16, 1999
          (the "Agreement").
     B.   The Parties wish to amend the terms of the Agreement pursuant to
          paragraph 15 of the Agreement.
     C.   Digirad is licensing from Segami a modified version of Segami's
          Acquisition software, and Segami's current processing and display
          software, both known under the trade name Mirage.
     D.   Digirad desires to develop its own applications, related to
          acquisition or processing tasks, to run on the Mirage platform.

     In consideration of the mutual promises and covenants herein contained, the
receipt and sufficiency of which are hereby acknowledged, the parties agree
under seal as follows:

1.   DEFINITION:

     "Digirad Application": an application specified and developed by Digirad's
     engineers, with or without help from Segami, using the Mirage development
     platform, without modifying existing Mirage applications.

2.   DELIVERABLES:

     Segami shall deliver its standard version 5 development kit to Digirad,
     i.e. all .dll and .lib library files, with all associated .hpp headers,
     some sample source code, plus the current documentation on the platform and
     its libraries, as is. There will be no support for Mirage version 4.

3.   FEES.

     For the duration of the current Agreement, Segami grants Digirad a
     non-exclusive license to the Mirage development environment, at no
     additional charge.

     A one-week training session for 2 or 3 Digirad engineers in Segami's
     facilities will be offered at no charge (travel, lodging and meal expenses
     will be the responsibility of Digirad).

     Segami's services to help Digirad develop its own applications are
     available to Digirad as part of the technical assistance covered under the
     current Agreement, at the same hourly rate, and without increasing the
     total guaranteed number of hours.

<Page>

4.   RESPONSIBILITY.

     Segami shall assume no responsibility whatsoever for the applications
     developed by Digirad. Segami makes no guarantee that applications developed
     by Digirad using the version 5 development platform will work as intended
     with any other version of Mirage, or any other similar Segami product.

5.   OWNERSHIP RIGHTS.

     Segami shall retain all right title and interest in the libraries,
     including changes that Segami may make to the libraries at Digirad's
     request, and in the Mirage product in its entirety.

     Digirad shall have all right, title and interest, in the applications that
     it develops.

6.   INCORPORATION BY REFERENCE.

     This Addendum shall be governed and interpreted as part of the Agreement
     and its general terms and conditions. If any conflict exists, or is
     determined by a court or arbitrator to exist, between the Agreement and
     this Addendum, the Agreement shall be controlling.

In witness whereof, the Parties have caused this Addendum to be executed under
seal as of the date first above written.

ATTEST                                     Segami Corporation

 /s/ ILLEGIBLE                             By:   /s/ PHILIPPE BRIANDET
--------------------------------               -----------------------------
Secretary                                  Philippe Briandet, President

                                           Digirad Corporation
--------------------------------
Secretary

                                           By:   /s/ ILLEGIBLE
                                               -----------------------------EXHIBIT 10.20

 

INDEMNIFICATION
AGREEMENT

 

This INDEMNIFICATION AGREEMENT (this “Agreement”)
is made and entered into this         
day of
                          ,
20       
(the “Effective Date”) by and between Digirad Corporation, a Delaware
corporation (the “Company”),
and                            (the
“Indemnitee”).

 

WHEREAS, the Company believes it is essential to
retain and attract qualified directors and officers;

 

WHEREAS, the Indemnitee is or intends to become a
director and/or officer of the Company;

 

WHEREAS, both the Company and the Indemnitee recognize
the increased risk of litigation and other claims being asserted against
directors and officers of public companies; 

 

WHEREAS, the Company’s Restated Certificate of
Incorporation (the “Certificate of Incorporation”) and Restated Bylaws
(the “Bylaws”) require the Company to indemnify and advance expenses to
its directors and officers to the extent permitted by the DGCL (as hereinafter
defined); 

 

WHEREAS, in recognition of the Indemnitee’s need for
(i) substantial protection against personal liability based on the
Indemnitee’s reliance on the Certificate of Incorporation and Bylaws,
(ii) an inducement to provide effective services to the Company as a
director and/or officer thereof, the Company wishes to provide for the
indemnification of the Indemnitee and to advance expenses to the Indemnitee to
the fullest extent permitted by law and as set forth in this Agreement, and, to
the extent insurance is maintained by the Company, to provide for the continued
coverage of the Indemnitee under the Company’s directors’ and officers’
liability insurance policies; and

 

WHEREAS, the Indemnitee (i) has been serving and
intends to continue serving as a director and/or officer of the Company in part
in reliance on the Certificate of Incorporation and Bylaws; or (ii) is relying upon the rights afforded under this
Agreement in accepting Indemnitee’s position as a director, officer or employee
of the Company; 

 

NOW, THEREFORE, in consideration of the premises contained
herein and of the Indemnitee continuing to serve the Company directly or, at
its request, with another enterprise, and intending to be legally bound hereby,
the parties hereto agree as follows:

 

1.             Certain
Definitions.

 

(a)           A
“Change in Control” shall, for purposes of this Agreement, be deemed to
have occurred if: 

 

(i)            any
“person,” as such term is used in Sections 13(d) and 14(d) of the
Securities Exchange Act of 1934, as amended, and the rules and regulations
thereunder (the “Exchange Act”), other than (a) a trustee or other
fiduciary holding securities under an employee benefit plan of the Company; (b)
a corporation owned, directly or indirectly, by the stockholders of the Company
in substantially the same proportions as their ownership of stock of the
Company; or (c) any current beneficial stockholder or group, as defined by Rule
13d-5 of the

 

 

Exchange Act, including the heirs, assigns and successors thereof, of
beneficial ownership, within the meaning of Rule 13d-3 of the Exchange Act, of
securities possessing more than 50% of the total combined voting power of the
Company’s outstanding securities; hereafter becomes the “beneficial owner,” as
defined in Rule 13d-3 of the Exchange Act, directly or indirectly, of
securities of the Company representing 20% or more of the total combined voting
power represented by the Company’s then outstanding Voting Securities;

 

(ii)           during
any period of two consecutive years, individuals who at the beginning of such
period constitute the Board and any new director whose election by the Board or
nomination for election by the Company’s stockholders was approved by a vote of
at least two-thirds of the directors then in office who either were directors
at the beginning of the period or whose election or nomination for election was
previously so approved, cease for any reason to constitute a majority thereof;
or

 

(iii)          the stockholders of the Company approve a
merger or consolidation of the Company with any other corporation, other than a
merger or consolidation which would result in the Voting Securities of the
Company outstanding immediately prior thereto continuing to represent (either
by remaining outstanding or by being converted into Voting Securities of the
surviving entity) at least 80% of the total voting power represented by the
Voting Securities of the Company or such surviving entity outstanding
immediately after such merger or consolidation, or the stockholders of the
Company approve a plan of complete liquidation of the Company or an agreement
for the sale or disposition by the Company, in one transaction or a series of
transactions, of all or substantially all of the Company’s assets.

 

(b)           “DGCL”
shall mean the General Corporation Law of the State of Delaware, as the same
exists or may hereafter be amended or interpreted; provided, however, that in
the case of any such amendment or interpretation, only to the extent that such
amendment or interpretation permits the Company to provide broader
indemnification rights than were permitted prior thereto.

 

(c)           “Expense”
shall mean attorneys’ fees and all other costs, expenses and obligations paid
or incurred in connection with investigating, defending, being a witness in or
participating in (including on appeal), or preparing for any of the foregoing,
any Proceeding relating to any Indemnifiable Event.

 

(d)           “Indemnifiable
Event” shall mean any event or occurrence that takes place either prior to
or after the execution of this Agreement, related to the fact that the
Indemnitee is or was a director or officer of the Company, or is or was serving
at the request of the Company as a director, officer, employee, or agent of
another corporation or of a partnership, joint venture, trust or other
enterprise, including service with respect to employee benefit plans, or by
reason of anything done or not done by the Indemnitee in any such capacity.

 

(e)           “Proceeding”
shall mean any threatened, pending or completed action, suit, investigation or
proceeding, and any appeal thereof, whether civil, criminal, administrative or
investigative and/or any inquiry or investigation, whether conducted by the
Company or any other party, that the Indemnitee in good faith believes might
lead to the institution of any such action.

 

2

 

(f)            “Reviewing
Party” shall mean any appropriate person or body consisting of a member or
members of the Company’s Board or any other person or body appointed by the
Board (including the special independent counsel referred to in Section 6)
who is not a party to the particular Proceeding with respect to which the
Indemnitee is seeking indemnification.

 

(g)           “Voting
Securities” shall mean any securities of the Company which vote generally
in the election of directors.

 

2.             Indemnification.  In the event the Indemnitee was or
is a party to or is involved (as a party, witness, or otherwise) in any
Proceeding by reason of (or arising in part out of) an Indemnifiable Event,
whether the basis of the Proceeding is the Indemnitee’s alleged action in an
official capacity as a director or officer or in any other capacity while
serving as a director or officer, the Company shall indemnify the Indemnitee to
the fullest extent permitted by the DGCL against any and all Expenses,
liability, and loss (including judgments, fines, ERISA excise taxes or
penalties, and amounts paid or to be paid in settlement, and any interest,
assessments, or other charges imposed thereon, and any federal, state, local,
or foreign taxes imposed on any director or officer as a result of the actual
or deemed receipt of any payments under this Agreement) (collectively, “Liabilities”)
reasonably incurred or suffered by such person in connection with such
Proceeding.  The Company shall provide
indemnification pursuant to this Section 2 as soon as practicable, but in no
event later than 30 days after it receives written demand from the
Indemnitee.  Notwithstanding anything in
this Agreement to the contrary and except as provided in Section 5 below,
the Indemnitee shall not be entitled to indemnification pursuant to this
Agreement (i) in connection with any Proceeding initiated by the Indemnitee
against the Company or any director or officer of the Company unless the
Company has joined in or consented to the initiation of such Proceeding or (ii)
on account of any suit in which judgment is rendered against the Indemnitee
pursuant to Section 16(b) of the Exchange Act for an accounting of profits made
from the purchase or sale by the Indemnitee of securities of the Company.

 

3.             Advancement
of Expenses.  The Company
shall advance Expenses to the Indemnitee within 30 business days of such
request (an “Expense Advance”); provided, however, that if required by
applicable corporate laws such Expenses shall be advanced only upon delivery to
the Company of an undertaking by or on behalf of the Indemnitee to repay such
amount if it is ultimately determined that the Indemnitee is not entitled to be
indemnified by the Company; and provided further, that the Company shall make
such advances only to the extent permitted by law.  Expenses incurred by the Indemnitee while not acting in his/her
capacity as a director or officer, including service with respect to employee
benefit plans, may be advanced upon such terms and conditions as the Board, in
its sole discretion, deems appropriate.

 

4.             Review
Procedure for Indemnification.  Notwithstanding
the foregoing, (i) the obligations of the Company under Sections 2
and 3 above shall be subject to the condition that the Reviewing Party shall
not have determined (in a written opinion, in any case in which the special
independent counsel referred to in Section 6 hereof is involved) that the
Indemnitee would not be permitted to be indemnified under applicable law, and
(ii) the obligation of the Company to make an Expense Advance pursuant to
Section 3 above shall be subject to the condition that, if, when and to
the extent that the Reviewing Party determines that the Indemnitee would not be
permitted to be so indemnified under applicable law, the Company shall be
entitled to be reimbursed by the Indemnitee (who hereby agrees to reimburse the
Company) for all such

 

3

 

amounts theretofore paid; provided, however, that if the Indemnitee has
commenced legal proceedings in a court of competent jurisdiction pursuant to
Section 5 below to secure a determination that the Indemnitee should be
indemnified under applicable law, any determination made by the Reviewing Party
that the Indemnitee would not be permitted to be indemnified under applicable
law shall not be binding and the Indemnitee shall not be required to reimburse
the Company for any Expense Advance until a final judicial determination is
made with respect thereto (as to which all rights of appeal therefrom have been
exhausted or have lapsed).   The Indemnitee’s
obligation to reimburse the Company for Expense Advances pursuant to this
Section 4 shall be unsecured and no interest shall be charged thereon.  If there has not been a Change in Control,
the Reviewing Party shall be selected by the Board, and if there has been such
a Change in Control, other than a Change in Control which has been approved by
a majority of the Company’s Board who were directors immediately prior to such
Change in Control, the Reviewing Party shall be the special independent counsel
referred to in Section 6 hereof.

 

5.             Enforcement
of Indemnification Rights. 
If the Reviewing Party determines that the Indemnitee substantively
would not be permitted to be indemnified in whole or in part under applicable
law, or if the Indemnitee has not otherwise been paid in full pursuant to
Sections 2 and 3 above within 30 days after a written demand has been received
by the Company, the Indemnitee shall have the right to commence litigation in
any court in the State of Delaware having subject matter jurisdiction thereof
and in which venue is proper to recover the unpaid amount of the demand (an “Enforcement
Proceeding”) and, if successful in whole or in part, the Indemnitee shall
be entitled to be paid any and all Expenses in connection with such Enforcement
Proceeding.  The Company hereby consents
to service of process for such Enforcement Proceeding and to appear in any such
Enforcement Proceeding.  Any
determination by the Reviewing Party otherwise shall be conclusive and binding
on the Company and the Indemnitee.

 

6.             Change in
Control.  The Company agrees
that if there is a Change in Control of the Company, other than a Change in
Control which has been approved by a majority of the Company’s Board who were
directors immediately prior to such Change in Control, then with respect to all
matters thereafter arising concerning the rights of the Indemnitee to indemnity
payments and Expense Advances under this Agreement or any other agreement or
under applicable law or the Company’s Certificate of Incorporation or Bylaws
now or hereafter in effect relating to indemnification for Indemnifiable
Events, the Company shall seek legal advice only from special independent
counsel selected by the Indemnitee and approved by the Company, which approval
shall not be unreasonably withheld. 
Such special independent counsel shall not have otherwise performed
services for the Company or the Indemnitee, other than in connection with such
matters, within the last five years. 
Such independent counsel shall not include any person who, under the
applicable standards of professional conduct then prevailing, would have a
conflict of interest in representing either the Company or the Indemnitee in an
action to determine the Indemnitee’s rights under this Agreement.  Such counsel, among other things, shall
render its written opinion to the Company and the Indemnitee as to whether and
to what extent the Indemnitee would be permitted to be indemnified under
applicable law.  The Company agrees to
pay the reasonable fees of the special independent counsel referred to above
and to indemnify fully such counsel against any and all expenses (including
attorneys’ fees),

 

4

 

claims, liabilities and damages arising out of or relating to this Agreement
or the engagement of special independent counsel pursuant to this Agreement.

 

7.             Partial
Indemnity.  If the Indemnitee
is entitled under any provision of this Agreement to indemnification by the
Company for some or a portion of the Expenses and Liabilities, but not,
however, for all of the total amount thereof, the Company shall nevertheless
indemnify the Indemnitee for the portion thereof to which the Indemnitee is
entitled.  Moreover, notwithstanding any
other provision of this Agreement, to the extent that the Indemnitee has been
successful on the merits or otherwise in defense of any or all Proceedings
relating in whole or in part to an Indemnifiable Event or in defense of any
issue or matter therein, including dismissal without prejudice, the Indemnitee
shall be indemnified against all Expenses incurred in connection
therewith.  In connection with any
determination by the Reviewing Party or otherwise as to whether the Indemnitee
is entitled to be indemnified hereunder, the burden of proof shall be on the
Company to establish that the Indemnitee is not so entitled. 

 

8.             Non-exclusivity.  The rights of the Indemnitee hereunder shall
be in addition to any other rights the Indemnitee may have under any statute,
provision of the Company’s Certificate of Incorporation or Bylaws, vote of
stockholders or disinterested directors or otherwise, both as to action in an
official capacity and as to action in another capacity while holding such
office.  To the extent that a change in
the DGCL permits greater indemnification by agreement than would be afforded
currently under the Company’s Certificate of Incorporation and Bylaws and this
Agreement, it is the intent of the parties hereto that the Indemnitee shall
enjoy by this Agreement the greater benefits so afforded by such change.  

 

9.             Liability
Insurance.  To the extent the
Company maintains an insurance policy or policies providing directors’ and
officers’ liability insurance, the Indemnitee shall be covered by such policy
or policies, in accordance with its or their terms, to the maximum extent of
the coverage available for any director or officer of the Company.

 

10.           Settlement
of Claims.  The Company shall
not be liable to indemnify the Indemnitee under this Agreement (a) for any
amounts paid in settlement of any action or claim effected without the
Company’s written consent, which consent shall not be unreasonably withheld; or
(b) for any judicial award if the Company was not given a reasonable and timely
opportunity, at its expense, to participate in the defense of such action.

 

11.           No
Presumption.  For purposes of
this Agreement, to the fullest extent permitted by law, the termination of any
Proceeding, action, suit or claim, by judgment, order, settlement (whether with
or without court approval) or conviction, or upon a plea of nolo contendere, or
its equivalent, shall not create a presumption that the Indemnitee did not meet
any particular standard of conduct or have any particular belief or that a
court has determined that indemnification is not permitted by applicable law.

 

12.           Period of
Limitations.  No legal action
shall be brought and no cause of action shall be asserted by or on behalf of
the Company or any affiliate of the Company against the Indemnitee, the
Indemnitee’s spouse, heirs, executors or personal or legal representatives
after the expiration of two years from the date of accrual of such cause of
action, or such longer period as may be required by state law under the
circumstances, and any claim or cause of action of the

 

5

 

Company or its affiliate shall be extinguished and deemed released
unless asserted by the timely filing of a legal action within such period;
provided, however, that if any shorter period of limitations is otherwise
applicable to any such cause of action, such shorter period shall govern.

 

13.           Amendment of
this Agreement.  No
supplement, modification or amendment of this Agreement shall be binding unless
executed in writing by both of the parties hereto.  No waiver of any of the provisions of this Agreement shall be
deemed or shall constitute a waiver of any other provisions hereof (whether or
not similar), nor shall such waiver constitute a continuing waiver.  Except as specifically provided herein, no
failure to exercise or any delay in exercising any right or remedy hereunder
shall constitute a waiver thereof.

 

14.           Consent and
Waiver by Third Parties.  If
the Indemnitee is or will become an officer of the Company, then the Indemnitee
hereby represents and warrants that he or she has obtained all waivers and/or
consents from third parties which are necessary for his or her employment with
the Company on the terms and conditions set forth herein and to execute and
perform this Agreement without being in conflict with any other agreement,
obligation or understanding with any such third party.  The Indemnitee represents that he or she is
not bound by any agreement or any other existing or previous business
relationship which conflicts with, or may conflict with, the performance of his
or her obligations hereunder or prevent the full performance of his or her
duties and obligations hereunder.

 

15.           Subrogation.  In the event of payment under this
Agreement, the Company shall be subrogated to the extent of such payment to all
of the rights of recovery of the Indemnitee, who shall execute all papers
required and shall do everything that may be necessary to secure such rights,
including the execution of such documents necessary to enable the Company
effectively to bring suit to enforce such rights.

 

16.           No
Duplication of Payments.  The
Company shall not be liable under this Agreement to make any payment in
connection with any claim made against Indemnitee to the extent the Indemnitee
has otherwise actually received payment (under any insurance policy, Bylaw,
vote, agreement or otherwise) of the amounts otherwise indemnifiable hereunder.

 

17.           Binding
Effect.  This Agreement shall
be binding upon and inure to the benefit of and be enforceable by the parties
hereto and their respective successors, assigns, including any direct or
indirect successor by purchase, merger, consolidation or otherwise to all or
substantially all of the business and/or assets of the Company, spouses, heirs,
and personal and legal representatives. 
The Company shall require and cause any successor (whether direct or
indirect by purchase, merger, consolidation or otherwise) to all, substantially
all, or a substantial part, of the business and/or assets of the Company, by
written agreement in form and substance satisfactory to the Indemnitee,
expressly to assume and agree to perform this Agreement in the same manner and
to the same extent that the Company would be required to perform if no such
succession had taken place.  This Agreement
shall continue in effect regardless of whether the Indemnitee continues to
serve as a director or officer of the Company or of any other enterprise at the
Company’s request.

 

18.           Severability.  The provisions of this Agreement shall be
severable in the event that any of the provisions hereof (including any
provision within a single section, paragraph or

 

6

 

sentence) is held by a court of competent jurisdiction to be invalid,
void or otherwise unenforceable, and the remaining provisions shall remain
enforceable to the fullest extent permitted by law.  Furthermore, to the fullest extent possible, the provisions of
this Agreement (including, without limitation, each portion of this Agreement
containing any provision held to be invalid, void or otherwise unenforceable,
that is not itself invalid, void or unenforceable) shall be construed so as to
give effect to the intent manifested by the provision held invalid, illegal or
unenforceable.

 

19.           Governing
Law.  This Agreement shall be
governed by and construed and enforced in accordance with the laws of the State
of Delaware applicable to contracts made and to be performed in such State
without giving effect to the principles of conflicts of laws.

 

20.           Counterparts.  This Agreement may be executed in one or
more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

 

21.           Notices.  All notices, demands, and other
communications required or permitted hereunder shall be made in writing and
shall be deemed to have been duly given if delivered by hand, against receipt,
or mailed, postage prepaid, certified or registered mail, return receipt
requested, and addressed to the Company at:

 

Digirad Corporation

13950 Stowe Drive

Poway, CA 92064

Attention:  Chief Executive Officer

 

and to the Indemnitee at:

 

                                

                                

                                

                                

 

Notice of change of address shall be effective only
when done in accordance with this Section. 
All notices complying with this Section shall be deemed to have been
received on the date of delivery or on the third business day after mailing.

 

[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK]

 

7

 

IN WITNESS WHEREOF, the parties hereto have duly
executed and delivered this Agreement as of the day first set forth above.

 

	
   

  	
  COMPANY:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  DIGIRAD
  CORPORATION

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  INDEMNITEE:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Signature

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Print Name:

  	
   

  	
   

  
							

 

 

[SIGNATURE PAGE TO
INDEMNIFICATION AGREEMENT]

 

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00065-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00065-of-00352.parquet"}]]